Europe Melanoma Cancer Diagnostics Market Growth Insights and Outlook to 2032
The Europe Melanoma Cancer Diagnostics Market shows steady growth. Valued at USD 1.55 billion in 2024, the market is projected to reach USD 2.59 billion by 2032, expanding at a CAGR of 6.6% during 2025–2032. This report analyzes market dynamics, segmentation, drivers, restraints, opportunities, and competitive landscape, based exclusively on Data Bridge Market Research insights.
Understanding Melanoma Cancer Diagnostics
Melanoma diagnostics encompass instruments (dermatoscopes, imaging platforms) and consumables (biopsy kits, reagents) for detecting malignant melanocytes. Key tests include:
- Biomarkers → Genetic/protein markers (dominant in 2024).
- Imaging → Dermoscopy, AI-assisted (fastest-growing).
- Biopsy, FISH, CGH, IHC.
Globally, early detection improves survival; Europe benefits from national screening and AI tools.
Get More Information : https://www.databridgemarketresearch.com/reports/europe-melanoma-cancer-diagnostics-market
Market Size and Growth Projections
Rising incidence and tech advancements fuel growth. Valued at USD 1.55 billion in 2024, the market reaches USD 2.59 billion by 2032 at a CAGR of 6.6% (2025–2032).
| Metric | Value |
|---|---|
| Market Size (2024) | USD 1.55 Billion |
| Market Size (2032) | USD 2.59 Billion |
| CAGR (2025–2032) | 6.6% |
Market Segmentation
By Product Type
- Instruments → 41.5% share in 2024 (dermatoscopes, imaging).
- Consumables & Accessories → Fastest growth at 10.8% CAGR (biopsy kits, reagents).
- Others
By Test Type
- Biomarkers Test → 38.6% share in 2024 (genetic/protein markers).
- Imaging Test → Fastest-growing (AI dermoscopy).
- Biopsy, FISH, CGH, IHC, Others
By End User
- Hospitals → 45.2% share in 2024.
- Independent Diagnostic Laboratories → Fastest at 11.4% CAGR.
- Associated Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others
By Distribution Channel
- Direct Tender → 62% share in 2024 (bulk procurement).
- Retail Sales → Fastest at 12.1% CAGR.
By Countries
Germany (dominant), Italy (fastest-growing), France, U.K., Netherlands, Switzerland, Belgium, Russia, Spain, Turkey, Rest of Europe.
Key Drivers Fueling Growth
- Increasing melanoma incidence and awareness of early detection.
- Advancements in diagnostics (AI dermoscopy, molecular testing).
- Government initiatives for screening and preventive check-ups.
- Preference for non-invasive, accurate methods.
Restraints/Challenges
- High costs of advanced diagnostics (AI platforms, biomarkers).
- Regulatory hurdles and approvals across countries.
- Complex reimbursement policies.
Opportunities
- Adoption of AI-assisted platforms.
- Integration of digital health in workflows.
Competitive Landscape
Major players include:
- Sysmex Europe SE (Germany)
- BIOMÉRIEUX (France)
- Castle Biosciences, Inc. (U.S.)
- DermTech (U.S.)
- SYNLAB International (Germany)
- Biohit Oyj (Finland)
- Epigenomics AG (Germany)
- Damae Medical (France)
- SkylineDx (Netherlands)
- AMLo Biosciences Ltd (U.K.)
- Oxford Gene Technology IP Limited (U.K.)
- HYPHEN BioMed (France)
- Thermo Fisher Scientific Inc. (U.S.)
- Vermilion, Inc. (U.S.)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Siemens Healthineers AG (Germany)
- DiaSorin S.p.A. (Italy)
Recent developments:
- June 2025 → Málaga hospitals/L'Oréal 'SaVios' AI study with SkinVision app.
- May 2025 → AI Medical Technology's Dermalyser CE Mark (95.2% sensitivity).
- January 2025 → EADO updated melanoma guidelines.
- May 2024 → EU-funded skin cancer screening device.
- May 2024 → Bdetect portable light-based device.
Future Trends and Opportunities
Trends emphasize AI/digital integration and non-invasive tests. Opportunities in underserved regions and precision diagnostics.
Conclusion
The Europe Melanoma Cancer Diagnostics Market advances to USD 2.59 billion by 2032 at 6.6% CAGR, enabling early detection effectively. Stakeholders should leverage AI to address costs and seize screening opportunities. Prioritizing Germany's infrastructure and Italy's growth will ensure diagnostic success.
Browse More Reports:
Global Video Laryngoscope Market
France Flow Cytometry Market
Global Mobile Payment Technologies Market
Global Carbon Fiber Market
Global Gluten-free Vegan Snacks Market
Global Flow Cytometry Market
Global Men’s Skincare Products Market
Global Micro Data Center Market
Global Tennis Racquet Market
Global Agricultural Nanotechnology Market
Global Natural Food Colors Market
Global Barium Market
Global Center Pivot Irrigation Systems Market
Global Autonomous Underwater Vehicle (AUV) Market
Global Closed System Transfer Devices Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com
Patrocinados
Categorías
Read More
"Detailed Analysis of Executive Summary Bioprocessing Systems Market Size and Share The global bioprocessing systems market size was valued at USD 287.82 million in 2025 and is expected to reach USD 838.48 million by 2033, at a CAGR of 14.30% during the forecast period The Bioprocessing Systems report makes available the current and forthcoming...
"Executive Summary North America Pterygium Drug Market Research: Share and Size Intelligence Data Bridge Market Research analyses that the North America pterygium drug market will grow at a CAGR of 5.8% during the forecast period of 2022 to 2029. The credible North America Pterygium Drug report has estimations of CAGR values, which are very important for businesses in deciding upon...
"Executive Summary Asia-Pacific Prophylaxis of Organ Rejection Market Size and Share Analysis Report Asia-Pacific prophylaxis of organ rejection market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.0% in the forecast period of 2022 to 2029 and is expected to reach USD...
Executive Summary: Narrowband Internet of Things (IoT) Market Size and Share by Application & Industry CAGR Value The global Narrowband Internet of Things (IoT) market was valued at approximately USD 5.2 billion in 2024 and is projected to reach USD 9.6 billion by 2032, growing at a CAGR of 8.2% during the forecast period. For the growth of business, Narrowband Internet of...
Scars Treatment Market Segmentation, By Type (Keloid Scars, Hypertrophic Scars, Others), Product (Topical, Injectables, Laser, Atrophic, Contracture, Stretch Marks), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others) - Industry Trends and Forecast to 2032 Scars Treatment Market Size The Global...
